BlueRock Therapeutics società ha sostenuto
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
leggi di più
Working with people who are kind, knowledgeable & dedicated
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
Leadership recognizes the importance of acknowledgment & empowers all employees within their roles, regardless of position in company ladder
Cosa ti piace di più del team di leadership?
Leadership demonstrates being invested in the people doing the work and not just the work being done by their people
Other Employee Reviews for BlueRock Therapeutics
×